Stay updated on CT: ctDNA-Enriched Post-neoadjuvant Trial for Triple Negative Breast Cancer
Sign up to get notified when there's something new on the CT: ctDNA-Enriched Post-neoadjuvant Trial for Triple Negative Breast Cancer page.

Latest updates to the CT: ctDNA-Enriched Post-neoadjuvant Trial for Triple Negative Breast Cancer page
- Check5 days agoChange DetectedThe web page has updated its version from v2.16.6 to v2.16.8 and added a section on HHS Vulnerability Disclosure.SummaryDifference0.8%
- Check12 days agoChange DetectedThe web page has been updated from version 2.16.5 to version 2.16.6.SummaryDifference0.3%
- Check19 days agoChange DetectedA service alert has been added regarding planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours.SummaryDifference4%
- Check26 days agoChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a significant note regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.SummaryDifference4%
- Check33 days agoNo Change Detected
- Check41 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference4%
- Check55 days agoChange DetectedThe page has been updated to reflect a new funder decision and the termination of a previous status, with results now posted and a revision update to version 2.16.2. The date has also been changed to May 31, 2025.SummaryDifference2%
Stay in the know with updates to CT: ctDNA-Enriched Post-neoadjuvant Trial for Triple Negative Breast Cancer
Enter your email address, and we'll notify you when there's something new on the CT: ctDNA-Enriched Post-neoadjuvant Trial for Triple Negative Breast Cancer page.